149 related articles for article (PubMed ID: 31865605)
1. A real-life analysis on the indications and prognostic relevance of perioperative chemotherapy in locally advanced resectable gastric adenocarcinoma.
Pardo F; Osorio J; Miranda C; Castro S; Miró M; Luna A; Garsot E; Momblán D; Galofré G; Rodríguez-Santiago J; Pera M;
Clin Transl Oncol; 2020 Aug; 22(8):1335-1344. PubMed ID: 31865605
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
3. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
[TBL] [Abstract][Full Text] [Related]
4. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
5. D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy.
Shrikhande SV; Barreto SG; Talole SD; Vinchurkar K; Annaiah S; Suradkar K; Mehta S; Goel M
World J Surg Oncol; 2013 Feb; 11():31. PubMed ID: 23375104
[TBL] [Abstract][Full Text] [Related]
6. Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer.
Karagkounis G; Squires MH; Melis M; Poultsides GA; Worhunsky D; Jin LX; Fields RC; Spolverato G; Pawlik TM; Votanopoulos KI; Levine EA; Schmidt C; Bloomston M; Cho CS; Weber S; Masi A; Berman R; Pachter HL; Staley CA; Newman E; Maithel SK; Hatzaras I
J Gastrointest Surg; 2017 Dec; 21(12):1984-1992. PubMed ID: 28963709
[TBL] [Abstract][Full Text] [Related]
7. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
8. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
9. Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.
Pacelli F; Cusumano G; Rosa F; Marrelli D; Dicosmo M; Cipollari C; Marchet A; Scaringi S; Rausei S; di Leo A; Roviello F; de Manzoni G; Nitti D; Tonelli F; Doglietto GB;
JAMA Surg; 2013 Apr; 148(4):353-60. PubMed ID: 23715879
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
11. The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.
Oh SJ; Hyung WJ; Li C; Song J; Kang W; Rha SY; Chung HC; Choi SH; Noh SH;
J Surg Oncol; 2009 Apr; 99(5):275-80. PubMed ID: 19152367
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
13. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
15. Totally laparoscopic versus open gastrectomy for advanced gastric cancer: a matched retrospective cohort study.
Chan BYO; Yau KKW; Chan CKO
Hong Kong Med J; 2019 Feb; 25(1):30-7. PubMed ID: 30655459
[TBL] [Abstract][Full Text] [Related]
16. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
17. Extended multiorgan resection in locally advanced gastric cancer: a single centre experience from south India.
Deshpande G; Samarasam I; Chandran BS; Abraham V; George SV; Mathew G
Trop Gastroenterol; 2013; 34(4):259-63. PubMed ID: 25046889
[TBL] [Abstract][Full Text] [Related]
18. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for survival in patients with resectable advanced gastric adenocarcinoma].
Medrano-Guzmán R; Valencia-Mercado D; Luna-Castillo M; García-Ríos LE; González-Rodríguez D
Cir Cir; 2016; 84(6):469-476. PubMed ID: 27039288
[TBL] [Abstract][Full Text] [Related]
20. Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801).
Stahl M; Maderer A; Lordick F; Mihaljevic AL; Kanzler S; Hoehler T; Thuss-Patience P; Mönig S; Kunzmann V; Schroll S; Sandermann A; Tannapfel A; Meyer HJ; Schuhmacher C; Wilke H; Moehler M;
Eur J Cancer; 2018 Apr; 93():119-126. PubMed ID: 29501977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
